Metabolic Disease Has A Greater Effect On The Health of Our Society Than Cancer

United States of America (Press Release) October 13, 2007 -- This year we will be focusing on emerging approaches to treat the Metabolic Syndrome, including modulators of the mitochondrion and on steroid biosynthesis and we will hear about new agents in the battle against obesity. A special feature this year will be a Symposium on The New World of Insulin. We will devote our attention to insulin treatment as well as new approaches to Beta Cell preservation and regeneration.

Marc Rendell, the conference chairman states, “The Metabolic Summit is in its third year. The conference focuses on areas not covered in other major Meetings. We proudly bring together experts from both the academic and pharmaceutical world in our efforts to highlight major issues. This year we are featuring a Symposium on The new World of Insulin as well as a presentation of new approaches to The Metabolic Syndrome.” The main goal of the summit is to encourage the free flow of information among our participants.

Speakers will focus on advances for:
· Diabetes
· Insulin
· Cardiovascular Diseases
· Obesity
· Mitochondrial Function

At GTCbio conferences delegates are high level executives from pharmaceuticals, biotech companies and academia.
About The 3rd Metabolic Diseases World Summit:
The 3rd Metabolic Diseases World Summit taking place on November 1-2 in San Diego, CA is devoted to better understanding new options in dealing with this condition. Speakers from both academia and industry will focus on the advances of treatments for Metabolic Diseases and how they relate to Insulin, Diabetes, Obesity, Cardiovascular Disease and Mitochondrial Function.

For more information on this conference including a detailed agenda, exhibitor opportunities and registration go to: http://www.gtcbio.com/conference/conferenceDetails.aspx?id=9